✦ LIBER ✦

Novel Oral Anti-Obesity Agents: New Perspectives with Lorcaserin?

✍ Scribed by Gallwitz, Baptist

Book ID: 120299858
Publisher: Springer International Publishing AG
Year: 2013
Tongue: English
Weight: 167 KB
Volume: 73
Category: Article
ISSN: 0012-6667
DOI: 10.1007/s40265-013-0039-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

ChemInform Abstract: Tricyclic Dihydroqu

ChemInform Abstract: Tricyclic Dihydroquinazolinones as Novel 5-HT2C Selective and Orally Efficacious anti-Obesity Agents.

✍ Saleem Ahmad; et al. et al. 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 22 KB

Predictive value of serum anti-mullerian

Predictive value of serum anti-mullerian hormone in obese and non-obese wome with polycystic ovary syndrome (PCOS) receiving oral ovulation induction (OI) agents

✍ Uyenishi, J.; Vitek, W.; Queenan, J.; Bhagavath, B.; Hoeger, K. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 81 KB

BPR0C261 is a novel orally active antitu

BPR0C261 is a novel orally active antitumor agent with antimitotic and anti-angiogenic activities

✍ Chih-Bo Hu; Ching-Ping Chen; Teng-Kuang Yeh; Jen-Shin Song; Chi-Yen Chang; Jiunn 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 678 KB

Effect of Orlistat, a Novel Anti-Obesity

Effect of Orlistat, a Novel Anti-Obesity Agent, on the Pharmacokinetics and Pharmacodynamics of Pravastatin in Patients with Mild Hypercholesterolaemia

✍ Dr Charles Y. Oo, Bardia Akbari, Steve Lee, Gary Nichols, Christopher P. Hellman 📂 Article 📅 1999 🏛 Springer International Publishing AG 🌐 English ⚖ 267 KB

A radioimmunoassay combined with solid-p

A radioimmunoassay combined with solid-phase extraction for the determination of a novel anti-obesity agent, ARL 15849XX, in dog plasma

✍ Vivian J.C. Willson; John R. Preston; William J.S. Lockley; Jaspal Singh; David 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 512 KB

A radioimmunoassay has been developed for the determination of ARL 15849XX, a cholecystokinin-8 (CCK-8) analogue, in dog plasma. The method incorporates solid-phase sample extraction and is suitable for the determination of the analyte at picogram per millilitre concentrations. The antiserum was rai

First results of a phase I and pharmacok

First results of a phase I and pharmacokinetic study of SU011248, a novel oral anti-angiogenic agent, in patients with advanced solid tumours

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 132 KB